Article (Scientific journals)
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
Antunes, Manuel J.; Rodriguez-Palomares, Jose; Prendergast, Bernard et al.
2017In European Journal of Cardio-Thoracic Surgery
Peer Reviewed verified by ORBi
 

Files


Full Text
EUR J CARDIO THORAC SURG 52 1022.pdf
Publisher postprint (369.39 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Guidelines; Tricuspid valve; Tricuspid valve regurgitation
Abstract :
[en] Tricuspid regurgitation (TR) is a very frequent manifestation of valvular heart disease. It may be due to the primary involvement of the valve or secondary to pulmonary hypertension or to the left-sided heart valve disease (most commonly rheumatic and involving the mitral valve). The pathophysiology of secondary TR is complex and is intrinsically connected to the anatomy and function of the right ventricle. A systematic multimodality approach to diagnosis and assessment (based not only on the severity of the TR but also on the assessment of annular size, RV function and degree of pulmonary hypertension) is, therefore, essential. Once considered non-important, treatment of secondary TR is currently viewed as an essential concomitant procedure at the time of mitral (and, less frequently, aortic valve) surgery. Although the indications for surgical management of severe TR are now generally accepted (Class I), controversy persists concerning the role of intervention for moderate TR. However, there is a trend for intervention in this setting, especially at the time of surgery for left-sided heart valve disease and/or in patients with significant tricuspid annular dilatation (Class IIa). Currently, surgery remains the best approach for the interventional treatment of TR. Percutaneous tricuspid valve intervention (both repair and replacement) is still in its infancy but may become a reliable option in future, especially for high-risk patients with isolated primary TR or with secondary TR related to advanced left-sided heart valve disease.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Antunes, Manuel J.
Rodriguez-Palomares, Jose
Prendergast, Bernard
De Bonis, Michele
Rosenhek, Raphael
Al-Attar, Nawwar
Barili, Fabio
Casselman, Filip
Folliguet, Thierry
Iung, Bernard
Lancellotti, Patrizio  ;  Université de Liège - ULiège > Département des sciences cliniques > Imagerie cardiaque fonctionnelle par échographie
Muneretto, Claudio
Obadia, Jean-Francois
Pierard, Luc ;  Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Suwalski, Piotr
Zamorano, Pepe
More authors (6 more) Less
Language :
English
Title :
Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.
Publication date :
2017
Journal title :
European Journal of Cardio-Thoracic Surgery
ISSN :
1010-7940
eISSN :
1873-734X
Publisher :
Elsevier, Netherlands
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
(c) The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Available on ORBi :
since 24 February 2018

Statistics


Number of views
1164 (3 by ULiège)
Number of downloads
895 (1 by ULiège)

Scopus citations®
 
123
Scopus citations®
without self-citations
110
OpenCitations
 
98

Bibliography


Similar publications



Contact ORBi